Sanofi India · NSE: SANOFI · BSE: 500674
Q3 FY24 results · Oct–Dec 2023
Sanofi India reported revenue from operations of ₹693.90 crore and net profit of ₹137.70 crore for Q3 FY24 (Oct–Dec 2023), on a consolidated basis.
| Item | Q3 FY24 | Q3 FY23 | YoY | Q2 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 693.90 | — | — | 714.58 | −2.9% |
| Other income | 12.00 | — | — | 11.82 | +1.5% |
| Total income | 705.90 | — | — | 726.40 | −2.8% |
| Profit before tax | 188.80 | — | — | 209.88 | −10.0% |
| Net profit for the period | 137.70 | — | — | 151.95 | −9.4% |
| EPS, basic (₹) | 59.79 | — | — | 65.95 | −9.3% |
| Net margin (%) | 19.8 | — | 21.3 |
| Item | Q3 FY24 | Q3 FY23 | YoY | Q2 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 693.90 | 671.90 | +3.3% | 714.58 | −2.9% |
| Other income | 12.00 | 20.00 | −40.0% | 11.82 | +1.5% |
| Total income | 705.90 | 691.90 | +2.0% | 726.40 | −2.8% |
| Profit before tax | 188.80 | 190.40 | −0.8% | 210.07 | −10.1% |
| Net profit for the period | 137.70 | 130.90 | +5.2% | 152.14 | −9.5% |
| EPS, basic (₹) | 59.79 | 56.84 | +5.2% | 66.08 | −9.5% |
| Net margin (%) | 19.8 | 19.5 | 21.3 |
Consolidated
- Filed with BSE
- 26 Feb 2024, 10:23 IST
- Board meeting
- 23 Feb 2024
- Period
- 01 Oct 2023 to 31 Dec 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 26 Feb 2024, 10:23 IST
- Board meeting
- 23 Feb 2024
- Period
- 01 Oct 2023 to 31 Dec 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE